A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...
Vous n'êtes pas connecté
A new editorial was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.” As highlighted in this editorial, TP53 mutations (mut) occur in 10–15% of acute myeloid leukemia (AML) cases, and they are commonly associated with therapy-related AML (t-AML) and complex cytogenetics (CG). TP53-mut AML is inherently resistant to [...]
A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...
In avatar therapy, a clinician gives voice to their patients’ inner demons. For some of the participants in a new trial, the results have been...
THURSDAY, Oct. 24, 2024 -- For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly...
THURSDAY, Oct. 31, 2024 -- Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in...
25, October 2024. Kano State’s Director-General of Media and Publicity, Sanusi Bature Dawakin-Tofa has announced the passing of his 15-year-old son,...
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...
Competitive: Bristol Myers Squibb: Working with Us Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job....
WEDNESDAY, Oct. 30, 2024 -- For children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, elevated body mass index (BMI)...
Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults.